Burkitt Lymphoma

Incidence and onset information

Alternative names

Burkitt Lymphoma Is also known as small non-cleaved cell lymphoma.

Researches and researchers

Doctors, researchs, and experts related to Burkitt Lymphoma extracted from public data.

Burkitt Lymphoma Experts map

Current Researchs and researchers

• VILLEJUIF — Dr Laurence BRUGIERES

  Clinical geneticist - Investigator of research project
  
  

  • Institution/s:
    — CLCC Institut Gustave Roussy
    — CLCC Institut Gustave Roussy
  • Research area/topic::
    

    Study on the Diagnostic Qualities of the Positron Emission Tomography Coupled to the Scanner (PET / CT) in the Assessment of Response to Non-Hodgkin's Lymphoma Therapy in Children and Adolescents



• ULM — Pr Reiner SIEBERT

  Clinical expert - Clinical geneticist - Investigator of research project - Coordinator of research network - Director of department
  
  

  • Institution/s:
    — Universitätsklinikum Ulm
  • Research area/topic::
    

    Malignant Lymphoma - Germinal center B-cell derived lymphomas - Project contributes to the International Cancer Genome Consortium (ICGC)



• WÜRZBURG — Pr Andreas ROSENWALD

  Responsible for diagnostic tests - Investigator of research project - Manager of biobank/collection - Director of laboratory
  
  

  • Institution/s:
    — Institut für Pathologie der Universität Würzburg
  • Research area/topic::
    

    Molecular pathogenesis of malignant B cell lymphoma



• GENOVA — Dr Giovanna CUTRONA

  Investigator of research project
  
  

  • Institution/s:
    — Oncologia Medica, Istituto Nazionale per la Ricerca sul Cancro - IST
  • Research area/topic::
    

    Burkitt's lymphoma: relevance to therapy and prevention. Study of therapies in mouse animal models



• PERUGIA — Pr Cristina MECUCCI

  Clinical expert - Responsible for diagnostic tests - Investigator of research project - Director of laboratory - Quality manager
  
  

  • Institution/s:
    — Università degli Studi di Perugia - Ospedale S. Maria della Misericordia
  • Research area/topic::
    

    Characterization of chromosomal breakpoints in hematological malignancies using molecular cytogenetics

Burkitt Lymphoma Recommended genes panels

Panel Name, Specifity and genes Tested/covered
Detection by FISH of C-MYC (8q24) rearrangements. By CGC Genetics (Portugal). MYC Specificity 100 % Genes 100 %
Detection by FISH of t(8;14) MYC/IGH. By CGC Genetics (Portugal). IGH, MYC Specificity 50 % Genes 100 %
Cancer Hotspot Panel. By Centogene AG - the Rare Disease Company (Germany). BCL6, ROS1, BRAF, BRCA1, BRCA2, SMARCB1, SMO, SRC, STK11, HNF1A, TP53, TSC1, TSC2, VHL, EML4, BRD4, CCND1, CCNE1, FBXW7, CD74 , (...) View the complete list with 68 more genes Panel complete gene list BCL6, ROS1, BRAF, BRCA1, BRCA2, SMARCB1, SMO, SRC, STK11, HNF1A, TP53, TSC1, TSC2, VHL, EML4, BRD4, CCND1, CCNE1, FBXW7, CD74, CDH1, CDK4, CDK6, CDKN2A, CDKN2B, KEAP1, CSF1R, CTNNB1, DDR2, RICTOR, RPTOR, EGFR, ERBB2, ERBB4, EZH2, FGFR1, FGFR2, FGFR3, FLT3, AKT1, MTOR, ALK, GNA11, GNA13, GNAI2, GNAQ, GNAS, GNAT2, GNG2, HRAS, IDH1, IDH2, APC, JAK2, JAK3, KDR, KIF5B, KIT, KRAS, AR, ARAF, SMAD4, MDM2, MET, MLH1, MPL, MYC, MYCL, MYCN, ABL1, NF1, NF2, NFE2L2, NOTCH1, NPM1, ATM, NRAS, NRG1, NTRK1, PDGFRA, PDGFRB, ATR, PIK3CA, PTCH1, PTEN, PTPN11, RB1, RET Close Specificity 2 % Genes 100 %
Fluorescent in situ Hybridization - Hematopathology. By Hartford Hospital Laboratory - Molecular Genetics and Cytogenetics Hartford Hospital-Hartford-CT-USA (United States). BCL6, BCR, RUNX1, ABI1, TCF3, TP53, DLEU1, CRLF2, RUNX1T1, CBFB, CDKN2A, CDKN2C, CKS1B, ETV6, MECOM, FGFR1, IGH, JAK2, MYC, ABL1 , (...) View the complete list with 7 more genes Panel complete gene list BCL6, BCR, RUNX1, ABI1, TCF3, TP53, DLEU1, CRLF2, RUNX1T1, CBFB, CDKN2A, CDKN2C, CKS1B, ETV6, MECOM, FGFR1, IGH, JAK2, MYC, ABL1, ATM, PBX1, PDGFRA, PDGFRB, PML, RARA, RB1 Close Specificity 4 % Genes 100 %
FISH, Lymphoma Panel. By Cytogenetics and Molecular Pathology Laboratory UP Health System Marquette (United States). BCL6, CCND1, IGH, MALT1, MYC Specificity 20 % Genes 100 %
MYC. By Fulgent Genetics Fulgent Genetics (United States). MYC Specificity 100 % Genes 100 %
Onco microarray for CLL. By Pittsburgh Cytogenetics Laboratory University of Pittsburgh Medical Center (United States). BCL6, TP53, BCL11A, CCND1, FGF2, AKT1, ALK, IGH, ITK, MYB, MYBL1, MYC, ATM, BCL10, BCL3 Specificity 7 % Genes 100 %
Focus::DLBCL&FL™ NGS Panel. By Cancer Genetics, Inc. Cancer Genetics, Inc. (United States). BCL6, SGK1, BRAF, ARID1A, BTK, STAT3, STAT6, SYK, TNFAIP3, FAS, TP53, IKZF1, IKZF3, CARD11, CD79A, CD79B, CDKN2A, CDKN2B, SOCS1, CREBBP , (...) View the complete list with 23 more genes Panel complete gene list BCL6, SGK1, BRAF, ARID1A, BTK, STAT3, STAT6, SYK, TNFAIP3, FAS, TP53, IKZF1, IKZF3, CARD11, CD79A, CD79B, CDKN2A, CDKN2B, SOCS1, CREBBP, TET2, EP300, EZH2, FOXO1, MTOR, GNA13, GNAI2, IRF4, KRAS, CIITA, KMT2D, MYC, MYD88, NOTCH1, ATM, PIK3CD, PIM1, PLCG2, B2M, PRDM1, PRKDC, PTEN, BCL10 Close Specificity 3 % Genes 100 %

Sources and references

You can check the following sources for additional information.

If you liked this article maybe you will also find interesting the following in-depth articles about other rare diseases, like SCLEROSTEOSIS 2; SOST2 PALMOPLANTAR KERATODERMA, EPIDERMOLYTIC; EPPK JOUBERT SYNDROME 23; JBTS23 GLYCEROL KINASE DEFICIENCY; GKD HYPEROXALURIA, PRIMARY, TYPE I; HP1